D Russell-Jones

Summary

Affiliation: Royal Surrey County Hospital
Country: UK

Publications

  1. ncbi Molecular, pharmacological and clinical aspects of liraglutide, a once-daily human GLP-1 analogue
    David Russell-Jones
    Department of Diabetes and Endocrinology, Royal Surrey County Hospital, Egerton Road, Guildford GU2 7XX, UK
    Mol Cell Endocrinol 297:137-40. 2009
  2. ncbi Psychometric properties of two measures of psychological well-being in adult growth hormone deficiency
    Carolyn V McMillan
    Department of Psychology, Royal Holloway, University of London, Egham, Surrey, TW20 0EX, UK
    Health Qual Life Outcomes 4:16. 2006
  3. ncbi Insulin-associated weight gain in diabetes--causes, effects and coping strategies
    David Russell-Jones
    Department of Diabetes and Endocrinology, Royal Surrey County Hospital, Guildford, Surrey, UK
    Diabetes Obes Metab 9:799-812. 2007
  4. ncbi Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen
    David Russell-Jones
    Royal Surrey County Hospital, Egerton Road, Guildford GU2 5XX, Surrey, United Kingdom
    Clin Ther 26:724-36. 2004
  5. ncbi Insulin detemir: improving the predictability of glycaemic control
    D Russell-Jones
    The Royal Surrey County Hospital and University of Surrey, Guildford, UK
    Int J Obes Relat Metab Disord 28:S29-34. 2004
  6. ncbi Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial
    D Russell-Jones
    Department of Diabetes and Endocrinology, Royal Guildford Hospital, UK
    Diabetologia 52:2046-55. 2009
  7. ncbi The safety and tolerability of GLP-1 receptor agonists in the treatment of type-2 diabetes
    D Russell-Jones
    Department of Diabetes and Endocrinology, Cedar Centre at the Royal Surrey County Hospital, Guildford, UK
    Int J Clin Pract 64:1402-14. 2010
  8. ncbi Insulin analogues: an example of applied medical science
    B Sheldon
    Centre for Diabetes, Endocrinology and Research CEDAR, Royal Surrey County Hospital, University of Surrey, Guildford, UK
    Diabetes Obes Metab 11:5-19. 2009
  9. ncbi Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with Type 2 diabetes and normal lipids
    A L Brackenridge
    Centre for Diabetes, Endocrinology and Research, Royal Surrey County Hospital, Guildford, Surrey GU2 7XX, UK
    Diabet Med 26:532-9. 2009
  10. ncbi Emergency management of diabetes and hypoglycaemia
    A Brackenridge
    Royal Surrey County Hospital, Guildford, Surrey, UK
    Emerg Med J 23:183-5. 2006

Collaborators

Detail Information

Publications12

  1. ncbi Molecular, pharmacological and clinical aspects of liraglutide, a once-daily human GLP-1 analogue
    David Russell-Jones
    Department of Diabetes and Endocrinology, Royal Surrey County Hospital, Egerton Road, Guildford GU2 7XX, UK
    Mol Cell Endocrinol 297:137-40. 2009
    ....
  2. ncbi Psychometric properties of two measures of psychological well-being in adult growth hormone deficiency
    Carolyn V McMillan
    Department of Psychology, Royal Holloway, University of London, Egham, Surrey, TW20 0EX, UK
    Health Qual Life Outcomes 4:16. 2006
    ....
  3. ncbi Insulin-associated weight gain in diabetes--causes, effects and coping strategies
    David Russell-Jones
    Department of Diabetes and Endocrinology, Royal Surrey County Hospital, Guildford, Surrey, UK
    Diabetes Obes Metab 9:799-812. 2007
    ..Elucidation of the pharmacological mechanisms underlying this property might help clarify the mechanisms linking insulin with weight regulation...
  4. ncbi Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen
    David Russell-Jones
    Royal Surrey County Hospital, Egerton Road, Guildford GU2 5XX, Surrey, United Kingdom
    Clin Ther 26:724-36. 2004
    ....
  5. ncbi Insulin detemir: improving the predictability of glycaemic control
    D Russell-Jones
    The Royal Surrey County Hospital and University of Surrey, Guildford, UK
    Int J Obes Relat Metab Disord 28:S29-34. 2004
    ..The improved predictability in insulin response offered by insulin detemir may be associated with a number of clinical benefits including a reduction in hypoglycaemia and weight gain...
  6. ncbi Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial
    D Russell-Jones
    Department of Diabetes and Endocrinology, Royal Guildford Hospital, UK
    Diabetologia 52:2046-55. 2009
    ..The aim of the study was to compare the efficacy and safety of liraglutide in type 2 diabetes mellitus vs placebo and insulin glargine (A21Gly,B31Arg,B32Arg human insulin), all in combination with metformin and glimepiride...
  7. ncbi The safety and tolerability of GLP-1 receptor agonists in the treatment of type-2 diabetes
    D Russell-Jones
    Department of Diabetes and Endocrinology, Cedar Centre at the Royal Surrey County Hospital, Guildford, UK
    Int J Clin Pract 64:1402-14. 2010
    ..GLP-1 receptor agonists thus offer a new and potentially useful option for clinicians concerned about some of the common adverse effects of type-2 diabetes therapies...
  8. ncbi Insulin analogues: an example of applied medical science
    B Sheldon
    Centre for Diabetes, Endocrinology and Research CEDAR, Royal Surrey County Hospital, University of Surrey, Guildford, UK
    Diabetes Obes Metab 11:5-19. 2009
    ..Clinical studies have shown a lower relative risk of hypoglycaemia and detemir appears to have a weight-sparing action. Insulin analogues represent a successful example of applied medical science...
  9. ncbi Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with Type 2 diabetes and normal lipids
    A L Brackenridge
    Centre for Diabetes, Endocrinology and Research, Royal Surrey County Hospital, Guildford, Surrey GU2 7XX, UK
    Diabet Med 26:532-9. 2009
    ..The aim of this study was to perform a quantitative lipoprotein turnover study to determine the effects of PPAR-gamma agonists on lipoprotein metabolism...
  10. ncbi Emergency management of diabetes and hypoglycaemia
    A Brackenridge
    Royal Surrey County Hospital, Guildford, Surrey, UK
    Emerg Med J 23:183-5. 2006
    ..CONCLUSIONS: Hypoglycaemia is the commonest diabetic emergency and current management is suboptimal. Standardised protocols and better education of healthcare professionals and patients are required...
  11. ncbi Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial
    Philip Home
    Department of Diabetes and Metabolism, University of Newcastle upon Tyne, Newcastle upon Tyne, UK
    Diabetes Care 27:1081-7. 2004
    ..Accordingly, insulin detemir has been compared with NPH insulin with respect to glycemic control (HbA1c, prebreakfast glucose levels and variability, and hypoglycemia) and timing of administration...
  12. ncbi Contrasting insulin sensitivity of endogenous glucose production rate in subjects with hepatocyte nuclear factor-1beta and -1alpha mutations
    Anna Brackenridge
    Department of Diabetes and Endocrinology, Royal Surrey County Hospital, Guildford, UK
    Diabetes 55:405-11. 2006
    ..This is likely to reflect reduced action of HNF-1beta in the liver and possibly the kidney. This may be mediated through regulation by HNF-1beta of the key gluconeogenic enzymes glucose-6-phosphatase or PEPCK...